Shigefumi Maesaki

InstitutionSaitama Medical University
AddressSaitama
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in March 2021
    All Publications
    Bar chart showing 122 publications over 27 distinct years, with a maximum of 17 publications in 1998 and 1999
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Matsuzaki N, Orihara Y, Kodana M, Kitagawa Y, Matsuoka M, Kawamura R, Takeuchi S, Imai K, Tarumoto N, Maesaki S, Maeda T. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test. J Med Virol. 2021 Dec; 93(12):6778-6781. PMID: 34170555.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    2. Kodana M, Kitagawa Y, Takahashi R, Matsuoka M, Fushimi N, Sakai J, Ishibashi N, Imai K, Takeuchi S, Tarumoto N, Maesaki S, Ikezono T, Maeda T. Concerns about the clinical usefulness of saliva specimens for the diagnosis of COVID-19. J Infect. 2021 07; 83(1):119-145. PMID: 33872667.
      Citations:    Fields:    Translation:Humans
    3. Kubota K, Kitagawa Y, Matsuoka M, Imai K, Orihara Y, Kawamura R, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Maesaki S, Maeda T. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays. Diagn Microbiol Infect Dis. 2021 Jul; 100(3):115370. PMID: 33744623.
      Citations: 1     Fields:    Translation:Humans
    4. Imai K, Kitagawa Y, Tabata S, Kubota K, Nagura-Ikeda M, Matsuoka M, Miyoshi K, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Ito T, Maesaki S, Tamura K, Maeda T. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan. J Med Virol. 2021 May; 93(5):3211-3218. PMID: 33620098.
      Citations: 4     Fields:    Translation:Humans
    5. Satomura A, Oikawa Y, Nakanishi S, Takagi S, Mizutani G, Iida S, Nakayama H, Haga Y, Nagata M, Maesaki S, Mimura T, Shimada A. Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report. Diabetol Int. 2021 Mar 01; 1-6. PMID: 33680692.
      Citations: 1     
    6. Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol. 2020 11; 55(11):1098-1106. PMID: 32776161.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    7. Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol. 2021 Jan; 93(1):99-101. PMID: 32530491.
      Citations: 10     Fields:    Translation:Humans
    8. Sakai J, Tarumoto N, Orihara Y, Kawamura R, Kodana M, Matsuzaki N, Matsumura R, Ogane K, Kawamura T, Takeuchi S, Imai K, Murakami T, Maesaki S, Maeda T. Evaluation of a high-speed but low-throughput RT-qPCR system for detection of SARS-CoV-2. J Hosp Infect. 2020 Aug; 105(4):615-618. PMID: 32446722.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    9. Kitagawa Y, Orihara Y, Kawamura R, Imai K, Sakai J, Tarumoto N, Matsuoka M, Takeuchi S, Maesaki S, Maeda T. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification. J Clin Virol. 2020 08; 129:104446. PMID: 32512376.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    10. Imai K, Tabata S, Ikeda M, Noguchi S, Kitagawa Y, Matuoka M, Miyoshi K, Tarumoto N, Sakai J, Ito T, Maesaki S, Tamura K, Maeda T. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. J Clin Virol. 2020 07; 128:104393. PMID: 32387968.
      Citations: 40     Fields:    Translation:HumansCellsPHPublic Health